1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Graft Versus Host Disease (GVHD)-Pipeline Insights, 2014

SUMMARY
DelveInsight’s,“ Graft Versus Host Disease (GVHD)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Graft Versus Host Disease (GVHD). This report provides information on the therapeutic development based on the Graft Versus Host Disease (GVHD) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Graft Versus Host Disease (GVHD)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Graft Versus Host Disease (GVHD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Graft Versus Host Disease (GVHD) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Graft Versus Host Disease (GVHD)
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Graft Versus Host Disease (GVHD) pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Graft Versus Host Disease (GVHD)-Pipeline Insights, 2014
Table of Contents
- Graft Versus Host Disease (GVHD) Overview
- Graft Versus Host Disease (GVHD) Pipeline Therapeutics
- Graft Versus Host Disease (GVHD) Therapeutics under Development by Companies
- Graft Versus Host Disease (GVHD) Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Graft Versus Host Disease (GVHD) Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Graft Versus Host Disease (GVHD) Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Graft Versus Host Disease (GVHD) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Graft Versus Host Disease (GVHD) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Graft Versus Host Disease (GVHD) - Discontinued Products
- Graft Versus Host Disease (GVHD) - Dormant Products
- Companies Involved in Therapeutics Development for Graft Versus Host Disease (GVHD)
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Graft Versus Host Disease (GVHD), 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Graft Versus Host Disease (GVHD) Assessment by Monotherapy Products
- Graft Versus Host Disease (GVHD) Assessment by Combination Products
- Graft Versus Host Disease (GVHD) Assessment by Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Stage and Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Molecule Type
- Graft Versus Host Disease (GVHD) Assessment by Stage and Molecule Type
- Graft Versus Host Disease (GVHD) Therapeutics - Discontinued Products
- Graft Versus Host Disease (GVHD) Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Graft Versus Host Disease (GVHD), 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Graft Versus Host Disease (GVHD) Assessment by Monotherapy Products
- Graft Versus Host Disease (GVHD) Assessment by Combination Products
- Graft Versus Host Disease (GVHD) Assessment by Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Stage and Route of Administration
- Graft Versus Host Disease (GVHD) Assessment by Molecule Type
- Graft Versus Host Disease (GVHD) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Market Study on Bone Marrow Transplant: Latin America to Register Highest Growth Rate by 2021, Owing to Increasing Density of Bone Marrow Transplant Centers, Persistence Market Research

Global Market Study on Bone Marrow Transplant: Latin America to Register Highest Growth Rate by 2021, Owing to Increasing Density of Bone Marrow Transplant Centers, Persistence Market Research

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

Bone marrow transplant or hematopoietic stem cell transplant is the surgical procedure to replace impaired bone marrow tissue or bone marrow stem cells with healthy ones. Bone marrow transplant procedure ...

Transplantation Diagnostics Global Market - Forecast to 2022

Transplantation Diagnostics Global Market - Forecast to 2022

  • $ 4500
  • Industry report
  • August 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Transplantation is a surgical procedure of transferring organ, tissue or cell taken from one part of the body and grafted into another area of the same individual or another individual of same species ...

Organ And Tissue Transplantation - Global Market Outlook (2016-2022)

Organ And Tissue Transplantation - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Organ and Tissue Transplantation market is estimated to be $XX billion in 2015 and is expected to reach $XX billion by 2022 growing at a CAGR of XX% from 2015-2022. ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.